Home/Filings/4/0001415889-25-009616
4//SEC Filing

LEVIN ARTHUR A 4

Accession 0001415889-25-009616

CIK 0001623526other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:03 PM ET

Size

7.9 KB

Accession

0001415889-25-009616

Insider Transaction Report

Form 4
Period: 2025-03-31
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-31+1,2101,210 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-311,2103,632 total
    Exp: 2025-12-31Common Stock (1,210 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    17,979
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F2]The award vested or vests as to 1/4 of the total award quarterly on the last day of March, June, September, and December, subject to the reporting person's continued service to the issuer through each vesting date.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001181556

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:03 PM ET
Size
7.9 KB